Soluble TNF receptor levels.

(A) TNF levels rose to an identical degree in patients while receiving IL-1Ra and placebo and for 11 days after the infusion was complete. (B) Despite the presence of high circulating levels of IL-1Ra, the development of acute GVHD and/or the development of transplantation-related toxicity resulted in elevations in TNF levels.